Details for Patent: 9,585,868

Which drugs does patent 9,585,868 protect, and when does it expire?

Patent 9,585,868 protects MYTESI and is included in one NDA.

This patent has twenty-seven patent family members in twenty-one countries.

Summary for Patent: 9,585,868

Title:	Methods and compositions for treating HIV-associated diarrhea
Abstract:	Presented herein are methods for treating diarrhea by administering to a patient in need thereof, an inhibitor of chloride-ion transport in an amount sufficient to treat diarrhea. Treatment of diarrhea includes the treatment of the diarrhea as well as the pain, abdominal discomfort and other symptoms associated with diarrhea. In one embodiment, the inhibitor of chloride-ion transport is crofelemer.
Inventor(s):	Forbes; William (Raleigh, NC), Bortey; Enoch (Chapel Hill, NC), King; Steven (Moss Beach, CA), Chaturvedi; Pravin (Andover, MA)
Assignee:	NAPO PHARMACEUTICALS, INC. (San Francisco, CA)
Application Number:	14/597,740
Patent Claim Types: see list of patent claims	Use;

Drugs Protected by US Patent 9,585,868

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Napo Pharms Inc	MYTESI	crofelemer	TABLET, DELAYED RELEASE;ORAL	202292-001	Dec 31, 2012		RX	Yes	Yes						SYMPTOMATIC RELIEF OF NON-INFECTIOUS DIARRHEA

International Family Members for US Patent 9,585,868

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2011320155
Brazil	112013010774
Canada	2816416